Start for free
Start for free
SLS Venture logo

SLS Venture

Europe, Stockholms Lan, Sweden, Stockholm

Description

SLS Venture, a Scandinavian-based venture capital company, is the result of the merger of the life science team from The Sixth Swedish

Investor Profile

SLS Venture has made 14 investments, with 0 in the past 12 months and 21% as lead.

Stage Focus

  • Series C (29%)
  • Series Unknown (29%)
  • Series B (21%)
  • Series A (14%)
  • Series D (7%)

Country Focus

  • United States (43%)
  • Denmark (36%)
  • Sweden (14%)
  • Germany (7%)

Industry Focus

  • Biotechnology
  • Health Care
  • Hospital
  • Medical Device
  • Medical
  • Pharmaceutical
  • Health Diagnostics
  • Biopharma
  • Oncology
  • Genetics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does SLS Venture frequently co-invest with?

China Development Industrial Bank (CDIB)
China Development Industrial Bank (CDIB)
Asia, T'ai-pei, Taiwan, Taipei
Co-Investments: 1
SEB Venture Capital
SEB Venture Capital
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 1
Essex Woodlands Healthcare Partners
Essex Woodlands Healthcare Partners
North America, California, United States, Palo Alto
Co-Investments: 3
Johnson & Johnson Development Corporation
Johnson & Johnson Development Corporation
North America, New Jersey, United States, New Brunswick
Co-Investments: 1
Novo Holdings
Novo Holdings
Europe, Hovedstaden, Denmark, Hellerup
Co-Investments: 4
LD Pensions
LD Pensions
Europe, Nordjylland, Denmark, Aalborg
Co-Investments: 8
NB
Nordic Biotech
North America, South Carolina, United States, Denmark
Co-Investments: 1
Larkspur Capital Corporation
Larkspur Capital Corporation
North America, New York, United States, New York
Co-Investments: 1
Adams Street Partners
Adams Street Partners
North America, Illinois, United States, Chicago
Co-Investments: 1
HealthCap
HealthCap
Europe, Stockholms Lan, Sweden, Stockholm
Co-Investments: 2

What are some of recent deals done by SLS Venture?

AdvanDx

Woburn, Massachusetts, United States

AdvanDx is a biotech company offering molecular vitro diagnostic kits for the identification and prevention of infectious diseases.

BiotechnologyHealth CareHospitalMedical Device
Series UnknownApr 8, 2014
Amount Raised: $12,000,000
Action Pharma

Aarhus, Midtjylland, Denmark

Action Pharma develops pharmaceutical products and treatment concepts for cardiovascular, inflammatory and acquired metabolic diseases.

BiotechnologyHealth CarePharmaceutical
Series CJul 16, 2010
Amount Raised: $6,300,000
AdvanDx

Woburn, Massachusetts, United States

AdvanDx is a biotech company offering molecular vitro diagnostic kits for the identification and prevention of infectious diseases.

BiotechnologyHealth CareHospitalMedical Device
Series COct 12, 2009
Amount Raised: $8,000,000
AdvanDx

Woburn, Massachusetts, United States

AdvanDx is a biotech company offering molecular vitro diagnostic kits for the identification and prevention of infectious diseases.

BiotechnologyHealth CareHospitalMedical Device
Series CSep 18, 2007
Amount Raised: $15,000,000
OxThera

Stockholm, Stockholms Lan, Sweden

OxThera develops products for the treatment of metabolic disorders resulting from excess levels of oxalate.

BiotechnologyHealth CareHealth Diagnostics
Series UnknownJun 29, 2007
Amount Raised: $21,905,530
AdvanDx

Woburn, Massachusetts, United States

AdvanDx is a biotech company offering molecular vitro diagnostic kits for the identification and prevention of infectious diseases.

BiotechnologyHealth CareHospitalMedical Device
Series BMay 8, 2006
Amount Raised: $5,000,000
Symphogen

Lyngby, Hovedstaden, Denmark

Symphogen is a biotechnology company that produces recombinant polyclonal antibody drugs for disease treatment and prevention.

BiopharmaBiotechnologyPharmaceutical
Series DJan 10, 2006
Amount Raised: $25,000,000
Light Sciences Oncology

Bellevue, Washington, United States

Light Sciences Oncology develops light-activated drug products to treat patients with solid tumor cancers.

BiotechnologyHealth CareMedicalOncologyPharmaceutical
Series ADec 14, 2005
Amount Raised: $32,000,000
OxThera

Stockholm, Stockholms Lan, Sweden

OxThera develops products for the treatment of metabolic disorders resulting from excess levels of oxalate.

BiotechnologyHealth CareHealth Diagnostics
Series UnknownJul 11, 2005
Amount Raised: $20,969,479
Exiqon

Vedbæk, Hovedstaden, Denmark

Exiqon operates in two business areas, Life Sciences and Diagnostics.

BiotechnologyGeneticsHealth CareHealth DiagnosticsLife ScienceMedical
Series UnknownJun 3, 2005
Amount Raised: $20,000,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator